Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Open Access
- 14 January 2020
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 10 (1) , 43
Abstract
Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual tumor. HIPEC increases concentrations of chemotherapy directly within the peritoneal cavity compared with the intravenous route and reduces the systemic side effects associated with prolonged adjuvant intraperitoneal exposure. Furthermore, hyperthermia increases tissue penetration and is synergistic with the therapeutic chemotherapy agents used. In ovarian cancer, evidence is building for its use in both primary and recurrent scenarios. In this review, we examine the history of HIPEC, the techniques used, and the available data guiding its use in primary and recurrent ovarian cancer.Keywords
This publication has 48 references indexed in Scilit:
- Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian CancerInternational Journal of Gynecological Cancer, 2012
- Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancerEuropean Journal of Surgical Oncology, 2011
- Surgical responsibilities in the management of peritoneal carcinomatosisJournal of Surgical Oncology, 2010
- Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancerJournal of Surgical Oncology, 2010
- Radical surgery‐peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancerJournal of Surgical Oncology, 2006
- Intraperitoneal Cisplatin and Paclitaxel in Ovarian CancerNew England Journal of Medicine, 2006
- Intraperitoneal hyperthermic chemotherapy in ovarian cancerInternational Journal of Gynecological Cancer, 2005
- Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal CancerJournal of Clinical Oncology, 2003
- Total abdominal colectomy, pelvic peritonectomy, and end‐ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non‐gynecologic cancerJournal of Surgical Oncology, 2003
- Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian CancerNew England Journal of Medicine, 1996